RxDoctor Payments Data

Joshua Sibille, MD

Vascular Surgery · Lafayette, LANPI 1992029904

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $12,962 of the $16,663 with a category attached, or 77.8%. 29 manufacturers reported payments, led by Medtronic at 39.5% of the total. 2025 is the largest year on record at $5,652, 2.7 times the $2,069 reported in 2019.

$16,663in general payments, 2019–2025

Across 236 payments — averaging $70.60 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medtronic$7K
  • Inari Medical, Inc.$2K
  • Penumbra, Inc.$2K
  • Terumo Medical Corporation$1K
  • Lemaitre Vascular, Inc.$853
  • Silk Road Medical, Inc.$796
  • plus $4K from 23 others

What the payments were for

  • Speaking & faculty fees$1,4259%
  • Travel & lodging$2,27614%
  • Food & beverage$12,96278%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$16,663 in reported general payments places this provider in the 75th percentile of 65 vascular surgery providers in Louisiana.

See all vascular surgery providers in Louisiana

Medicare billing

Part B allowed, 2024
$132,732
Medicare patients
427
Services billed
838

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Cilostazol32$367
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen71$264
ClopidogrelClopidogrel Bisulfate40$182

Paid to pharmacies, not to this prescriber.

Other vascular surgery in Lafayette

See the full list for Louisiana

Where these figures come from

Is this you, or does something look wrong? →